
SAFE Builder – $250k
Bala Ingredients provides access to the Serendial White Paper only to qualified investors, strategic partners, and authorized reviewers.
Because Serendial is a pre-patent, proprietary neuromodulating molecule, the white paper, and any scientific, regulatory, and technical information cannot be shared publicly.
Once your information is reviewed and approved we will send your Confidential Review Agreement to be signed. After it is signed and returned, you will receive access to the Serendial White Paper. This gated process protects the integrity of our intellectual property.
To receive access, please complete the form below: